The Global Heart Implants Market size is projected to reach USD 11.5 billion by 2020, at a CAGR of 9.9% from 2021-2028. The cardiac rhythm management devices segment is expected to hold the largest share among all product type segments during the forecast period and its demand will be driven by the increasing prevalence of serious arrhythmias globally, which is one of the major application areas for this type of device. North America is likely to dominate the global heart implants market with more than 40% revenue share, due to higher adoption rates for novel products such as implantable cardioverter defibrillators (ICDs), pacemaker leads, and ventricular assist devices (VADs).
Heart implants are devices used to treat the heart, usually as a result of an illness or accident. The implant can have different functions such as treating arrhythmia, managing irregular heartbeats, and improving blood flow by helping prevent clots from forming in coronary arteries after angioplasty surgery. These devices may be implanted directly into the patient's heart during open-heart surgery or they can be inserted through a tube that is passed from another artery (less invasive).
Heart implants are used to treat a variety of heart conditions including Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, and Congestive Heart Failure. The implant can be made with different materials such as metal or plastic that is either self-expanding or balloon expanded due to the body heat.
On the basis Of Type, the market is segmented into Cardiac Rhythm Management Devices, Coronary Stent Devices and Prosthetic Heart Valves, Cardiac Assist Devices.
Cardiac Rhythm Management Devices are heart implants that help to maintain a regular heartbeat. These devices work as pacemakers, and the implantable cardioverter-defibrillator (ICD) arranges electrical pulses to regulate your heart rate when necessary. Cardiac Rhythm Management Devices can be used in people with heart problems, such as arrhythmias or congestive heart failure.
There are three types of Cardiac Rhythm Management Devices: pacemakers; implantable cardioverter-defibrillators (ICDs); and cardiac assist devices.
Pacemakers regulate the heartbeat to treat slow rhythms, which is caused by a problem with the electrical system that controls it. ICDs work similarly but also continuously monitor for irregular patterns known as “arrhythmias” and deliver shocks when required to reset the rhythm back into normal sinus beats. Coronary stent devices help improve blood flow by holding open narrowed arteries after a procedure called angioplasty.
Cardiac assist devices are used to help a weakened heart pump blood effectively and include left ventricular assists, centrifugal pumps, right ventricle support pumps, and extracorporeal membrane oxygenation.
A coronary stent is a tube-shaped medical device implanted in the blood vessels of the heart to keep them open. It can be used for example, when there’s been a blockage or narrowing caused by hard plaques inside the arteries. A cardiologist will either measure your artery and then decide on which size stent you need or they may use an imaging procedure (like angiography) that allows them to see if you have narrowed areas of your blood vessel before deciding what type of treatment might be required. Stents come in different sizes depending on how big it needs to fit into the opening – from small ones for babies up to large ones that are fitted onto adults.
There are valves that keep the blood flowing in one direction so that it does not backflow. The heart has four valves - two atria and two ventricles: Aortic Valve, Pulmonary Valve, Mitral valve or Bicuspid valve, Tricuspid valve, and Semilunar Valves. In case of a prosthetic valvular disease to be treated surgically, these may involve an artificial replacement device such as a mechanical (bioprosthesis) or biological (homograft) heart valve. This is usually done when there is no other alternative because of risk factors for surgical complications.
Cardiac Assist Devices are mechanical pumps used to provide circulatory support for the heart, in the case of a person with cardiogenic shock or congestive heart failure. These devices can be external, such as an intra-aortic balloon pump (IABP), or implanted inside the body like a left ventricular assist device (LVAD). LVADs have been approved by FDA to help bridge patients until they receive donor's hearts and transplantation is possible. The implantable LVAD has two components: one that sits on top of your beating heart and another part below your rib cage called the power source unit which houses batteries and electronics.
On the basis of Application, the market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Congestive Heart Failure, and Others. Arrhythmia is the most common cardiovascular disease in which electrical activity of the heart becomes irregular or abnormal causing symptoms such as palpitations and dizziness.
On the basis of Region, the market is segmented into North America, Latin America, Europe, and the Asia Pacific. The market is dominated by regions in the Americas with a share of 56.13%. Europe has also been witnessing substantial expansion in the global cardiac implants market with an increase in demand for heart devices thereby leading to increased revenue generation from this region. The Asia Pacific accounted for only 12.92% share in terms of volume but it is anticipated that its contribution will grow significantly, which will result in an increment in the overall size of the Asia-Pacific Market during 2021-2028.
Up Market Research published a new report titled “Heart Implants Market research report which is segmented by Types (Cardiac Rhythm Management Devices, Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Assist Devices), By Applications (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Congestive Heart Failure, Others), By Players/Companies Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular Inc., Edwards Life-sciences Corporation., Abbott, Thoratec Corporation, SynCardia Systems, Inc.”.
|Report Attributes||Report Details|
|Report Title||Heart Implants Market Research Report|
|By Type||Cardiac Rhythm Management Devices, Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Assist Devices|
|By Application||Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Congestive Heart Failure, Others|
|By Companies||Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular Inc., Edwards Life-sciences Corporation., Abbott, Thoratec Corporation, SynCardia Systems, Inc.|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||246|
|Number of Tables & Figures||173|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Cardiac Rhythm Management Devices, Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Assist Devices and By Application Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Congestive Heart Failure, Others.
Some of the companies that are profiled in this report are:
Heart Implants Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Heart Implants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Heart Implants Market Report:
Some other reports from this category!